Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Spine Corp V.ASG

Alternate Symbol(s):  ASAPF

Aurora Spine Corporation is a designer and manufacturer of medical devices. The Company is engaged in the development and distribution of minimally invasive, interspinous fusion systems and devices. It offers a range of devices specifically designed to address cervical spine conditions and restore optimal functionality. Its Cervical product line includes apollo, Discovery, and DEXA-C. The apollo Anterior Cervical Plate system is comprised of cervical plates and bone screws constructed of titanium alloy as described by ASTM F136. Discovery is its Spine's invasive cervical interbody fusion system. The DEXA-C is crafted to mimic the lattice structure of cancellous bone in humans while maintaining a comparable modulus of elasticity. The Company has established a physician training program through national and regional cadaver labs.


TSXV:ASG - Post by User

Bullboard Posts
Comment by Screeferon Jul 08, 2016 2:57pm
168 Views
Post# 25036419

RE:ASG

RE:ASGPersonally, I like the direction it is taking.
It will take more time though unless they can further push the increased sales - which I think they are doing.

From Q1 financials:

In 2016, the company will focus on:

  • Aggressively continuing strategy of building a revenue base in the North American and European markets; the company will accomplish this by expanding product usages with its current distribution network, developing new distribution channels and training new surgeons on the Aurora product advantages;
  • Expanding sales teams in the United States by region

  Q1 2016 Q4 2015 Q3 2015 Q2 2015 Q1 2015
SALES 1,549,125 1,495,319 1,173,017 934,145 1,298,144
Cost of goods sold 744,094 731,166 429,875 425,945 622,518
GROSS PROFIT 805,031 764,153 743,142 508,200 675,626
GROSS MARGIN 52.0% 51.1% 63.4% 54.4% 52.0%
           
Gain on extinguishment of debt 205,316      
  805,031 969,469      
           
OPERATING EXPENSES        
Executive compensation 106,792 85,141 120,532 166,756 171,357
Salaries 313,642 342,278 338,890 351,455 456,824
Consulting fees 57,248 32,731 19,580 22,191 22,976
General and administrative 153,014 267,918 295,546 21,714 641,362
Research and development 8,408 21,858 4,440 11,044 40,777
Bad Debt          
Marketing 6,312 194,292 25,309 44,666 23,414
Occupancy 57,072 65,166 63,669 72,865 62,299
Professional fees 103,822 26,027 189,227 -36,026 233,795
Stock based compensation 44,615 50,884 50,884 50,884 40,789
Insurance 69,819 91,080 61,223 63,709 85,298
Depreciation 190,501 190,500 188,964 178,154 181,707
TOTAL OPERATING EXPENSES 1,111,245 1,367,875 1,358,264 947,412 1,960,598
           
NET LOSS -306,214 -603,722 -615,122 -439,212 -1,284,972

Bullboard Posts